Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

PharmTech Weekly News Roundup – Week of December 1, 2025

ByPatrick Lavery

December 5th 2025

Drug Digest: Closing the Gap in Modern Process Control and Automation for Quality

Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA

ByFeliza Mirasol

December 5th 2025

Aging process, rejuvenation anti-aging skin procedures old and young concept | Image Credit: © leszekglasner - stock.adobe.com

Immortal Dragons Will Help Etheros Target Aging and Related Diseases

ByPatrick Lavery

December 4th 2025

Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First

ByJayaprakash Nair

December 3rd 2025

Medical banner Pulmonary fibrosis on blue background | Image Credit: © mi_viri -stock.adobe.com

BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation

BySusan Haigney

December 2nd 2025

December 2004

Articles in this issue

Newsletter

Related Content

PharmTech Weekly News Roundup – Week of December 1, 2025

Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA

Immortal Dragons Will Help Etheros Target Aging and Related Diseases

Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First

BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation

Trending on Pharmaceutical Technology

FDA Deploys Agentic AI Capabilities for Agency Staff

Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First

BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation

Immortal Dragons Will Help Etheros Target Aging and Related Diseases

How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems